Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response –OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd.

We reviewed dozens of studies and spoke with researchers to find out whether any supplements demonstrate anti-inflammatory ...

The furthest intersection returns 49m at 6.1% CuEq1 and remains open at depth; These results will form part of the Mineral Resource Estimate update set for this quarterKEY POINTS Drilling from the end ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Abington Heights Sixth grader Leah Puttcamp is excelling academically and in both BMX and mountain bike racing, according to school officials. Over her young career she has more than 70 top-five ...

Mississippi has launched the REACH MS virtual teacher programme to address its critical teacher shortage. Through a $2.2 ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

Both experts said that with the consistent use of collagen-boosting skin care actives like retinoids, the textural ...

Harbaji, W. and Abdulai, A. (2025) Factors Influencing Schoolchildren’s Obesity: A Qualitative Document Analysis of ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...

Healthcare Trend Analysis Reveals Shift Toward Non-Invasive Pre-Surgical Evaluation as Multi-Modal Compression Technology Addresses Growing Patient Demand for Evidence-Based Alternatives ...